|Tested species reactivity||Mouse|
|Published species reactivity||Mouse, Not Applicable|
|Host / Isotype||Rat / IgG2a|
|Immunogen||CD4 (L3/T4) antigen|
|Storage buffer||PBS with 4-5mg/ml BSA|
|Contains||0.1% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||1.0 ug/10^6 cells|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-17449 targets CD4 in FACS applications and shows reactivity with Mouse samples.
The MA5-17449 immunogen is cD4 (L3/T4) antigen.
The CD4 antigen is involved in the recognition of the type II MHC antigen. It is also a receptor for HIV. It is present on most T helper cells and normal thymocytes. The cytoplasmic portion of CD4 is associated with p56lck tyrosine kinase. CD4 expression is commonly found in human lymph nodes and tonsils. CD27 (50 kDa) is a member of the tumor necrosis factor (TNF) receptor superfamily. CD40 and CD30 are also members of the TNF receptor superfamily. The TNF superfamily members are known for the regulation of cell proliferation and death. In contrast to the expression of other TNFR/TNF family members, expression of CD27 and its ligand CD70 is predominantly confined to lymphocytes. High expression levels of CD27 appear to be dependent on proper ligation of antigen receptors. CD70 expression requires additional co-stimulatory and/or pro-inflammatory signals. CD27 is a membranebound receptor, but a soluble form of CD27 is also produced.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||
Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
MA5-17449 was used in flow cytometry to characterize "class I APC-bald" mice and see if they develop diabetes
|de Jersey J,Snelgrove SL,Palmer SE,Teteris SA,Mullbacher A,Miller JF,Slattery RM||Proceedings of the National Academy of Sciences of the United States of America (104:1295)||2007|
|Not Applicable||Not Cited||
A transgenic mouse model for T-cell ignorance of a glial autoantigen.
MA5-17449 was used in flow cytometry to determine the fate of autoreactive CD4+T cells in HNT-TCR x GFAP-HA double transgenic mice
|Cabarrocas J,Piaggio E,Zappulla JP,Desbois S,Mars LT,Lassmann H,Liblau RS||Journal of autoimmunity (22:179)||2004|
Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production.
MA5-17449 was used in flow cytometry to examine the T cell responses in cyclophosphamide-treated mice after systemic infection with Candida albicans.
|Angulo I,Jiménez-Díaz MB,García-Bustos JF,Gargallo D,de las Heras FG,Muñoz-Fernández MA,Fresno M||Cellular immunology (218:46)||2002|
Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
MA5-17449 was used in flow cytometry to report that ectopic FasL expression prevents thyroid allograft rejection.
|Tourneur L,Malassagne B,Batteux F,Fabre M,Mistou S,Lallemand E,Lores P,Chiocchia G||Journal of immunology (Baltimore, Md. : 1950) (167:1338)||2001|
Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity.
MA5-17449 was used in flow cytometry to study regulation of the lck in T cell lineage commitment.
|Shimizu C,Kawamoto H,Yamashita M,Kimura M,Kondou E,Kaneko Y,Okada S,Tokuhisa T,Yokoyama M,Taniguchi M,Katsura Y,Nakayama T||International immunology (13:105)||2001|